Lookup NU author(s): Professor Tim Goodship
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Atypical haemolytic uraemic syndrome (aHUS) is a rare but life-threatening complement system-related disorder, characterized by renal failure, non-immune haemolytic anaemia and thrombocytopenia. We report on a young woman who developed a pancreatitis-induced aHUS following a routine procedure of endoscopic retrograde cholangiopancreatography. The patient was successively treated by 2 plasma exchanges with fresh frozen plasma and eculizumab, a monoclonal antibody designed to block terminal complement activation. The last treatment resulted in the immediate improvement of haemolytic parameters and to the definitive suspension of plasma exchanges. This is likely the first description of the use of a complement inhibitor to treat post-pancreatitis aHUS. We discussed treatment options and concluded that eculizumab could be a beneficial alternative to plasma exchanges in the management of such complications.
Author(s): Taton O, Delhaye M, Stordeur P, Goodship T, Le Moine A, Massart A
Publication type: Article
Publication status: Published
Journal: Acta Gastro-Enterologica Belgica
Print publication date: 01/04/2016
Acceptance date: 01/01/1900
ISSN (print): 0001-5644
Publisher: Universa Press